Skip to main content

Table 1 Baseline characteristics of all patients and patients within VAI tertiles

From: Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients

 

All patients

VAI tertiles

P value

 

Tertile 1 (0.32-1.41)

Tertile 2(1.42-3.24)

Tertile 3(3.25-31.66)

 

N = 464

N = 155

N = 155

N = 154

Age (year)

60 ± 12

59 ± 11

57 ± 13

62 ± 11

0.004

Gender (women,%)

51

43

45

64

<0.001

Diabetes mellitus (%)

50

34

47

69

<0.001

Dialysis vintage (years)

3.6 ± 3.7

3.6 ± 3.4

4.0 ± 4.6

3.1 ± 2.8

0.1

History of hypertension (%)

78

70

77

85

0.008

History of previous CVD No. (%)

109 (23)

28 (18)

31 (20)

50 (32)

0.005

Kt/Vurea

1.6 (1.3, 1.7)

1.5(1.4, 1.7)

1.6 (1.4, 1.7)

1.6 (1.4, 1.6)

0.5

Systolic BP (mmHg)

147 ± 30

139 ± 69

147 ± 50

148 ± 78

0.1

Diastolic BP (mmHg)

85 ± 13

85 ± 26

83 ± 15

86 ± 15

0.1

Body height (cm)

160 ± 8

160 ± 8

160 ± 9

159 ± 9

0.1

Body weight (Kg)

58   12

54 ± 10

59 ± 12

62 ± 13

<0.001

BMI (Kg.m−2)

22.7 ± 3.7

21 ± 2.9

22.7 ± 3.3

24.3 ± 4.0

<0.001

Waist circumference (cm)

84.9 ± 11.3

79.3 ± 8.8

85.7 ± 10.5

89.7 ± 11.9

<0.001

VAI

2.17 (1.17,4.12)

0.9(0.69,1.17)

2.19(1.76, 2.71)

5.12(4.12, 7.11)

<0.001

WHtR

0.53 ± 0.07

0.50 ± 0.05

0.53 ± 0.06

0.57 ± 0.07

<0.01

Laboratory data

     

Hemoglobin (g/dL)

11.0 ± 1.6

11.1 ± 1.5

11.1 ± 1.6

10.8 ± 1.6

0.1

K (mmol/L)

4.8 ± 0.8

4.9 ± 0.8

4.8 ± 0.8

4.7 ± 0.8

0.1

Ca (mg/dL); corrected

9.2 (8.8, 9.5)

9.0 (8.7, 9.4)

9.2 (8.8, 9.5)

9.3 (8.9, 9.8)

<0.001

P (mg/dL)

5.1 (4.3, 6.2)

5.0 (4.5, 6.2)

5.4 (4.2, 6.4)

5.0 (4.1, 6.0)

0.2

CaxP

47 (38, 56)

45 (39, 56)

49 (39, 59)

47 (38, 56)

0.4

T-CHO (mg/dL)

171 (145,200)

157 (137,192)

161(139, 192)

186(160,211)

<0.001

TG (mg/dL)

135 (92,212)

78 (62,98)

135(116,168)

256(193,321)

<0.001

LDL-C (mg/dL)

89 (67, 115)

81 (66, 108)

89 (68, 116)

97 (68, 118)

0.08

HDL-C (mg/dL)

46 (36, 57)

58 (49, 74)

45(37, 53)

36 (29, 42)

<0.001

iPTH (pg/mL)

234 (118, 438)

257 (131, 513)

238 (131, 423)

198(91, 412)

0.08

hs-CRP (mg/L)

3.4 (1.2, 8.2)

2.0 (0.8, 5.4)

4.1 (1.2, 10.1)

4.6 (2.2, 10.1)

<0.001

Albumin (g/L)

4.1 ± 0.4

4.1 ± 0.4

4.1 ± 0.4

4.0 ± 0.4

0.06

GNRI

103.3 ± 9.7

100.9 ± 8.5

103.6 ± 8.8

105.6 ± 11.0

<0.001

Medications (%)

     

ESA

94

93

93

95

0.1

Statins

23

24

22

20

0.1

Anti-hypertensive agents

53

51

51

55

0.2

  1. Abbreviations: VAI visceral adiposity index, CVD cardiovascular disease, BP blood pressure, BMI body mass index, WHtR waist-to-height ratio, K potassium, Ca calcium, P phosphorus, CaxP calcium phosphate product, T-CHO total cholesterol, TG triglyceride, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, iPTH intact parathyroid hormone, hs-CRP high-sensitive C-reactive protein, GNRI geriatric nutritional risk index, ESA erythropoiesis stimulating agents, Statins, HMG-CoA reductase inhibitors.
  2. Note: Conversion factors for units: hemoglobin in g/dL to g/L, ×10; serum calcium in mg/dL to mmol/L, ×0.2495; serum phosphate in mg/dL to mmol/L, ×0.3229; serum T-CHO in mg/dL to mmol/L,×0.02586;serum LDL-C in mg/dL to mmol/L, ×0.02586; serum TG in mg/dL to mmol/L, ×0.01129; serum albumin in g/dL to g/L, ×10. No conversion necessary for serum iPTH in pg/mL and ng/L; serum potassium in mEq/L and mmol/L.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840